Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

PBS140 offers good cold preservation in renal transplantation and now, crucially, has been shown to promote immediate function following warm ischemia. For a new cold preservation solution to compete with UW solution, improved efficacy and lower price may not be enough. Reducing rates of delayed graft function in organs from non-heart-beating and marginal donors might be the key.

Original publication

DOI

10.1038/sj.ki.5000230

Type

Journal article

Journal

Kidney Int

Publication Date

03/2006

Volume

69

Pages

784 - 785

Keywords

Adenosine, Allopurinol, Costs and Cost Analysis, Glutathione, Humans, Insulin, Kidney Transplantation, Organ Preservation, Organ Preservation Solutions, Raffinose, Tissue Donors